Skip to main content
Fig. 2 | Molecular Cancer

Fig. 2

From: Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma

Fig. 2

Performance evaluation of SubSigLnc-17 in the subtype classification and prognosis for DLBCL patients in the discovery cohort. a ROC analysis of the sensitivity and specificity of subtype prediction by the SubSigLnc-17. b Performance comparison in subtype prediction between SubSigLnc-17 and random lncRNAs. c Kaplan-Meier survival curves of overall survival between predicted GCB-like group and ABC-like group by SubSigLnc-17. d Kaplan-Meier survival curves of progression-free survival between predicted GCB-like group and ABC-like group by SubSigLnc-17

Back to article page

Molecular Cancer

ISSN: 1476-4598